請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30806
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江伯倫(Bor-luen Chiang) | |
dc.contributor.author | Yu-Han Liu | en |
dc.contributor.author | 劉羽涵 | zh_TW |
dc.date.accessioned | 2021-06-13T02:16:25Z | - |
dc.date.available | 2008-02-27 | |
dc.date.copyright | 2007-02-27 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-02-12 | |
dc.identifier.citation | Adachi, Y., Inaba, M., Inaba, K., Nagata, N., Kobayashi, Y., and Ikehara, S. (1993). Functional analyses of B cells in (NZW x BXSB) F1 mice. Autoimmunity 15, 99-105.
Andersen, H. R., Vinggaard, A. M., Rasmussen, T. H., Gjermandsen, I. M., and Bonefeld-Jorgensen, E. C. (2002). Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol Appl Pharmacol 179, 1-12. Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., and Powrie, F. (1999). An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190, 995-1004. Baechler, E. C., Batliwalla, F. M., Karypis, G., Gaffney, P. M., Ortmann, W. A., Espe, K. J., Shark, K. B., Grande, W. J., Hughes, K. M., Kapur, V., et al. (2003). Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100, 2610-2615. Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252. Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., and O'Garra, A. (2002). In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195, 603-616. Baumann, I., Kolowos, W., Voll, R. E., Manger, B., Gaipl, U., Neuhuber, W. L., Kirchner, T., Kalden, J. R., and Herrmann, M. (2002). Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46, 191-201. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., and Pascual, V. (2003). Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197, 711-723. Bernstein, K. A., Valerio, R. D., and Lefkowith, J. B. (1995). Glomerular binding activity in MRL lpr serum consists of antibodies that bind to a DNA/histone/type IV collagen complex. J Immunol 154, 2424-2433. Braissant, O., Foufelle, F., Scotto, C., Dauca, M., and Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366. Chen, Y. F., and Morel, L. (2005). Genetics of T cell defects in lupus. Cell Mol Immunol 2, 403-409. Clark, R. B. (2002). The role of PPARs in inflammation and immunity. J Leukoc Biol 71, 388-400. Cooper, G. S., Parks, C. G., Treadwell, E. L., St Clair, E. W., Gilkeson, G. S., Cohen, P. L., Roubey, R. A., and Dooley, M. A. (2002). Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11, 161-167. Cutolo, M., Sulli, A., Seriolo, B., Accardo, S., and Masi, A. T. (1995). Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 13, 217-226. de Waal Malefyt, R., Yssel, H., and de Vries, J. E. (1993). Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150, 4754-4765. Desvergne, B., and Wahli, W. (1999). Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20, 649-688. Donnelly, R. P., Dickensheets, H., and Finbloom, D. S. (1999). The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19, 563-573. Feinstein, D. L., Galea, E., Gavrilyuk, V., Brosnan, C. F., Whitacre, C. C., Dumitrescu-Ozimek, L., Landreth, G. E., Pershadsingh, H. A., Weinberg, G., and Heneka, M. T. (2002). Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol 51, 694-702. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170, 2081-2095. Gerlag, D. M., Ransone, L., Tak, P. P., Han, Z., Palanki, M., Barbosa, M. S., Boyle, D., Manning, A. M., and Firestein, G. S. (2000). The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol 165, 1652-1658. Gosset, P., Charbonnier, A. S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A. B., and Trottein, F. (2001). Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol 31, 2857-2865. Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., and Roncarolo, M. G. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742. Handwerger, B. S., Rus, V., da Silva, L., and Via, C. S. (1994). The role of cytokines in the immunopathogenesis of lupus. Springer Semin Immunopathol 16, 153-180. Harris, S. G., and Phipps, R. P. (2001). The nuclear receptor PPAR gamma is expressed by mouse T lymphocytes and PPAR gamma agonists induce apoptosis. Eur J Immunol 31, 1098-1105. Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., and Kalden, J. R. (1998). Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41, 1241-1250. Hsu, M. J., Lee, S. S., and Lin, W. W. (2002). Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol 72, 207-216. Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., and Howard, M. (1994). Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179, 305-310. Jakobsen, M. A., Petersen, R. K., Kristiansen, K., Lange, M., and Lillevang, S. T. (2006). Peroxisome proliferator-activated receptor alpha, delta, gamma1 and gamma2 expressions are present in human monocyte-derived dendritic cells and modulate dendritic cell maturation by addition of subtype-specific ligands. Scand J Immunol 63, 330-337. Kim, S. R., Lee, K. S., Park, H. S., Park, S. J., Min, K. H., Jin, S. M., and Lee, Y. C. (2005). Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma. Mol Pharmacol 68, 1568-1575. Kotzin, B. L. (1996). Systemic lupus erythematosus. Cell 85, 303-306. Kovacs, B., Vassilopoulos, D., Vogelgesang, S. A., and Tsokos, G. C. (1996). Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-alpha. Clin Immunol Immunopathol 81, 293-302. Levings, M. K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., and Roncarolo, M. G. (2001). IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166, 5530-5539. Licht, R., Dieker, J. W., Jacobs, C. W., Tax, W. J., and Berden, J. H. (2004). Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 22, 139-145. Lieu, C. W., Lee, S. S., and Wang, S. Y. (1992). The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12, 1211-1215. Lin, Y. L., Liang, Y. C., Lee, S. S., and Chiang, B. L. (2005). Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol 78, 533-543. Linker-Israeli, M. (1992). Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 63, 10-12. Liossis, S. N., Hoffman, R. W., and Tsokos, G. C. (1998). Abnormal early TCR/CD3-mediated signaling events of a snRNP-autoreactive lupus T cell clone. Clin Immunol Immunopathol 88, 305-310. Lutz, M. B., and Schuler, G. (2002). Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23, 445-449. Mok, C. C., and Lau, C. S. (2003). Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56, 481-490. Moore, K. W., de Waal Malefyt, R., Coffman, R. L., and O'Garra, A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19, 683-765. Nagaeva, O., Jonsson, L., and Mincheva-Nilsson, L. (2002). Dominant IL-10 and TGF-beta mRNA expression in gammadeltaT cells of human early pregnancy decidua suggests immunoregulatory potential. Am J Reprod Immunol 48, 9-17. Nambiar, M. P., Krishnan, S., and Tsokos, G. C. (2004). T-cell signaling abnormalities in human systemic lupus erythematosus. Methods Mol Med 102, 31-47. O'Garra, A., Stapleton, G., Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbis, D., Stall, A., Cupp, J., Moore, K., and et al. (1990). Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 2, 821-832. Piccirillo, C. A., and Thornton, A. M. (2004). Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 25, 374-380. Renaudineau, Y., Pers, J. O., Bendaoud, B., Jamin, C., and Youinou, P. (2004). Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3, 516-523. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., and Glass, C. K. (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79-82. Robson, M. G., and Walport, M. J. (2001). Pathogenesis of systemic lupus erythematosus (SLE). Clin Exp Allergy 31, 678-685. Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., and Levings, M. K. (2001). Type 1 T regulatory cells. Immunol Rev 182, 68-79. Rood, M. J., Van Der Velde, E. A., Ten Cate, R., Breedveld, F. C., and Huizinga, T. W. (1998). Female sex hormones at the onset of systemic lupus erythematosus affect survival. Br J Rheumatol 37, 1008-1010. Roubinian, J. R., Talal, N., Greenspan, J. S., Goodman, J. R., and Siiteri, P. K. (1979). Delayed androgen treatment prolongs survival in murine lupus. J Clin Invest 63, 902-911. Sanchez-Guerrero, J., Karlson, E. W., Liang, M. H., Hunter, D. J., Speizer, F. E., and Colditz, G. A. (1997). Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 40, 804-808. Sato, K., Yamashita, N., Yamashita, N., Baba, M., and Matsuyama, T. (2003). Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. Immunity 18, 367-379. Schandene, L., Alonso-Vega, C., Willems, F., Gerard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M., and Goldman, M. (1994). B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 152, 4368-4374. Schur, P. H. (1995). Genetics of systemic lupus erythematosus. Lupus 4, 425-437. Segal, R., Bermas, B. L., Dayan, M., Kalush, F., Shearer, G. M., and Mozes, E. (1997). Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol 158, 3009-3016. Sfikakis, P. P., Oglesby, R., Sfikakis, P., and Tsokos, G. C. (1994). B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 96, 8-14. Soto, A. M., Chung, K. L., and Sonnenschein, C. (1994). The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 102, 380-383. Stekman, I. L., Blasini, A. M., Leon-Ponte, M., Baroja, M. L., Abadi, I., and Rodriguez, M. A. (1991). Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis Rheum 34, 459-467. Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., and Wu, G. D. (1999). A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 104, 383-389. Taga, K., Mostowski, H., and Tosato, G. (1993). Human interleukin-10 can directly inhibit T-cell growth. Blood 81, 2964-2971. Taylor, P. R., Carugati, A., Fadok, V. A., Cook, H. T., Andrews, M., Carroll, M. C., Savill, J. S., Henson, P. M., Botto, M., and Walport, M. J. (2000). A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 192, 359-366. Theofilopoulos, A. N., and Lawson, B. R. (1999). Tumour necrosis factor and other cytokines in murine lupus. Ann Rheum Dis 58 Suppl 1, I49-55. VanBuskirk, A. M., Lesinski, G. B., Nye, K. J., Carson, W. E., and Yee, L. D. (2006). TGF-beta inhibition of CTL re-stimulation requires accessory cells and induces peroxisome-proliferator-activated receptor-gamma (PPAR-gamma). Am J Transplant 6, 1809-1819. Verthelyi, D., Petri, M., Ylamus, M., and Klinman, D. M. (2001). Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus 10, 352-358. Vieira, P. L., Christensen, J. R., Minaee, S., O'Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T., Stockinger, B., Wraith, D. C., and O'Garra, A. (2004). IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 172, 5986-5993. Wakeland, E. K., Wandstrat, A. E., Liu, K., and Morel, L. (1999). Genetic dissection of systemic lupus erythematosus. Curr Opin Immunol 11, 701-707. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/30806 | - |
dc.description.abstract | 介白質-10 (IL-10)是一種具有免疫抑制性的細胞激素,能夠抑制T細胞的活化及其功能,而對於調節性T細胞的分化也具有重要功能。介白質-10在許多自體免疫疾病之致病機轉中扮演的角色也益趨重要,例如全身性紅斑性狼瘡。若在週邊引起發炎反應的組織中給予介白質-10,可以降低發炎反應,並增強調節性T細胞之功能,則能預期對疾病症狀之舒緩,而作為細胞激素療法發展的學理根據。本論文著重於探討介白質-10的免疫調節功能對於抑制T細胞活化功能之機轉,我們觀察到給予介白質-10之T細胞株,會減少其IL-2之分泌量。我們也進一步研究介白質-10下游訊息的傳遞,並發現PPARγ的表現量在介白質-10刺激之下有明顯增加,同時,加入PPARγ的抑制劑會使介白質-10抑制T細胞IL-2分泌的情形獲得恢復。這些研究結果顯示,介白質-10對於T細胞的功能抑制可能是透過下游PPARγ的訊息傳遞,因此與PPARγ有關的訊息傳導路徑可能在自體免疫疾病中扮演著重要角色。為了進一步研究局部大量表現介白質-10與紅斑性狼瘡疾病舒緩之關聯,我們使用靈芝多醣體PSG,此成分能使樹突細胞與T細胞產生大量介白質-10,利用腹腔注射PSG的方式來治療狼瘡小鼠,治療結果發現小鼠周邊血中調節性T細胞之比例較高,腎絲球腎炎的情形較輕微,並有較長的壽命,說明了介白質-10在紅斑性狼瘡可能的療效。 | zh_TW |
dc.description.abstract | The immunosuppressive cytokine, interleukin-10, can inhibit the activation and effector functions of T cells. It also plays a key role in differentiation and function of a regulatory T cell subset. The role that IL-10 plays in the pathogenesis of many autoimmune diseases is striking, including systemic lupus erythematosus. Delivery of IL-10 cytokine alone in the inflammatory region to alleviate the severity of this disease, or enhance the function of regulatory T cells induced by the cytokine is the principle of tissue-specific cytokine treatment. In this study, we focused on the immune-modulatory effect of IL-10 in the activation of T cells. Decreased production of IL-2 was observed in different T cell lines when cultured with IL-10. To further study the inhibitory mechanisms of IL-10 on T cells, we examined the signaling pathways downstream of IL-10 and found the increased PPARγ expression was induced by IL-10 treatment. In addition, the inhibition of IL-2 secretion by IL-10 could be partially restored by PPARγ antagonist, GW9662. Our results suggest the inhibitory effect on T cells by interleukin-10 is partly through their downstream PPARγ. This molecule and its associated signal pathways should be taken into consideration for its potential of being new target in the development of immunotherapy against SLE. To further understand the effects of IL-10 on the disease development of SLE in vivo, we intraperitoneally injected PSG to NZB/W F1 mice to induce IL-10 production. After treatment, the mice have higher percentage of Treg population, lower glomerulonephritis, and greater survival tendencies. This suggests the potential role of IL-10 in the treatment of murine lupus. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T02:16:25Z (GMT). No. of bitstreams: 1 ntu-96-R93449005-1.pdf: 1414888 bytes, checksum: 82ea039eff8e1dad411b1428a9628f0d (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 謝誌…i
英文摘要…iii 中文摘要…v Chapter I. General Introducion 1.1 Background…2 1.1.1 Systemic lupus erythematosus…2 1.1.2 Murine model of lupus: NZB/W F1 mice…7 1.1.3 Interleukin-10…8 1.1.4 The role of interleukin-10 in SLE…9 1.1.5 The relationship of interleukin-10 and regulatory T cell function…10 1.1.6 Lentiviral vector…11 1.1.7 Peroxisome proliferator-activated receptor-gamma (PPARγ) …12 1.1.8 Polysaccharide components of Ganoderma lucidum (PSG) …14 1.2 Specific aims…15 Chapter II. Materials and Methods 2.1 Reagents…17 2.2 Cell lines…20 2.3 Plasmid construction…21 2.4 Transfection of COS-1 cells…22 2.5 Preparation of lentiviruses…22 2.6 Detection of cytokine expression by ELISA…23 2.7 Separation of splenic T cells by nylon wool…24 2.8 Stimulation of T cells…24 2.9 Letivirus transduction of splenic T cells…25 2.10 Detection of protein levels 2.10.1 SDS-PAGE…25 2.10.2 Western blot…26 2.11 Mice…27 2.12 In vivo treatment of PSG in NZB/W F1 mice…27 2.13 Examination of immunopathology 2.13.1 Detection of autoantibodies…28 2.13.2 Determination of renal pathology…29 2.14 Statistical analysis…30 Chapter III. Results 3.1 The inhibitory effect of IL-10 on T cell lines…32 3.2 Construction of pTYlinker-mIL10 plasmid for lentiviral delivery of mouse IL-10 gene 3.2.1 Construction of pTYlinker-mIL10 plasmid…32 3.2.2 IL-10-secreting capability of pTYlinker-mIL10 transfected cells…33 3.2.3 IL-10 production by lenti-mIL10 virus tranduced cells…33 3.2.4 Lenti-mIL10 virus-tranduction in mouse splenic T cells…34 3.3 The role of PPARγ in the inhibitory effect of IL-10 3.3.1 Ligand induced PPARγ expression in Jurkat cells…35 3.3.2 IL-10 induced PPARγ expression in human and mouse T cell lines…35 3.3.3 PPARγ antagonist reversed the inhibitory effect of IL-10 in human and mouse T cell lines…36 3.4 Application of PSG as an alternative way of local IL-10 induction for lupus treatment 3.4.1 PSG induced IL-10 production by dendritic cells of NZB/W F1 mice in vitro…36 3.4.2 PSG induced maturation of BMDC by enhancing the expression of DC surface markers and costimulatory molecules in vitro…37 3.5 PSG-treated lupus mice 3.5.1 Peripheral CD4+CD25+FoxP3+ regulatory T cells were increased after PSG treatment…38 3.5.2 Levels of autoantibodies in sera were no difference under PSG treatment…38 3.5.3 Clinical course and pathological changes of kidney…39 3.5.4 Prolonged survival of PSG-treated mice…40 Chapter IV. Discussion and perspectives…41 Figures…47 References…70 | |
dc.language.iso | en | |
dc.title | 介白質-10在狼瘡小鼠疾病調控機轉
所扮演的角色 | zh_TW |
dc.title | The Immune Regulatory Role of Interleukin-10
In Murine Lupus | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李建國,賴振宏 | |
dc.subject.keyword | 介白質-10,全身性紅斑性狼瘡,T細胞,自體免疫,過氧化小體增殖物活化受體,靈芝多醣體, | zh_TW |
dc.subject.keyword | Interleukin-10,Systemic lupus erythematosus,T cell,Autoimmune,Peroxisome proliferator-activated receptor(PPAR-gamma),The polysaccharide components of Gernderma lucidum(PSG), | en |
dc.relation.page | 82 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-02-12 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 免疫學研究所 | zh_TW |
顯示於系所單位: | 免疫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 1.38 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。